Allscripts Healthcare Solutions Inc
Allscripts Healthcare Solutions Inc operates in various business sectors.
Allscripts Healthcare Solutions Inc (AL21) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2022: 0.024x
Based on the latest financial reports, Allscripts Healthcare Solutions Inc (AL21) has a cash flow conversion efficiency ratio of 0.024x as of September 2022.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€28.14 Million) by net assets (€1.18 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Allscripts Healthcare Solutions Inc - Cash Flow Conversion Efficiency Trend (2018–2022)
This chart illustrates how Allscripts Healthcare Solutions Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Allscripts Healthcare Solutions Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Allscripts Healthcare Solutions Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
CTOS Digital Bhd
KLSE:5301
|
0.184x |
|
GHT Co Ltd Class A
SHE:300711
|
0.077x |
|
Formosa Advanced Technologies Co Ltd
TW:8131
|
0.027x |
|
Ginkgo Bioworks Holdings
NYSE:DNA
|
-0.094x |
|
Jiangxi Wannianqing Cement Co Ltd
SHE:000789
|
0.019x |
|
Southern Cable Group Bhd
KLSE:0225
|
0.036x |
|
Black Rock Coffee Bar, Inc. Class A Common Stock
NASDAQ:BRCB
|
0.049x |
|
Stockmann Oyj Abp
F:SOMB
|
0.156x |
Annual Cash Flow Conversion Efficiency for Allscripts Healthcare Solutions Inc (2018–2022)
The table below shows the annual cash flow conversion efficiency of Allscripts Healthcare Solutions Inc from 2018 to 2022.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2022-12-31 | €1.02 Billion | €115.56 Million | 0.114x | +301.66% |
| 2021-12-31 | €1.36 Billion | €-76.62 Million | -0.056x | +9.47% |
| 2020-12-31 | €1.67 Billion | €-103.66 Million | -0.062x | -272.85% |
| 2019-12-31 | €1.29 Billion | €46.25 Million | 0.036x | -16.22% |
| 2018-12-31 | €1.58 Billion | €67.89 Million | 0.043x | -- |